羊膜市场规模、份额和成长分析（按产品、应用、最终用途和地区划分）—产业预测（2026-2033 年）

预计到 2024 年，羊膜市场规模将达到 51.8 亿美元，到 2025 年将达到 59.6 亿美元，到 2033 年将达到 183.7 亿美元，在预测期（2026-2033 年）内，复合年增长率为 15.1%。

羊膜因其在多种疾病治疗中的疗效以及改善手术效果，在医疗保健市场，尤其是眼科和整形外科专家中备受关注。相关疾病患者数量的不断增长，推动了对创新羊膜产品的需求，以实现更有效率的手术介入。眼科手术中对组织基解决方案的日益关注，显着促进了市场扩张，因为此类解决方案有助于患者术后復原。此外，美容手术的日益普及预计也将进一步推动市场成长。冷冻保存技术、生物工程以及生物相容性支架的开发等技术进步，正在提升羊膜的功能，增强其组织修復和再生能力，从而满足医疗服务提供者和患者不断变化的需求。

羊膜市场驱动因素

户外工作者严重受伤事件的不断增加，是推动快速高效復健疗法需求成长的主要因素。创伤性损伤，尤其是儿童和青少年创伤性损伤，主要由道路交通事故造成，而道路交通事故仍是亟待解决的问题。随着全球对道路安全的日益关注和交通拥堵的加剧，交通事故的发生频率也不断上升。创伤性损伤病例的激增直接推动了羊膜市场的成长，因为医疗专业人员正在寻求先进的解决方案来促进此类损伤患者的康復和癒合。因此，羊膜市场正在蓬勃发展。

羊膜市场的限制

由于生产这些特殊产品及其相关服务的高成本，羊膜市场面临严峻的挑战。羊膜产品的生产需要复杂的生物过程和技术，这些对于确保安全性和保持其天然特性至关重要。严格的品管、全面的测试以及对监管标准的遵守是生产过程中的关键环节，这些因素共同导致了高昂的成本。由此产生的经济负担给患者、医疗服务提供者和医疗保健系统带来了障碍，并可能限制这些宝贵治疗方法的可近性和广泛应用。

羊膜市场趋势

羊膜市场正经历显着成长，这主要得益于新兴经济体，特别是亚太地区国家（如中国、印度和巴西）有利的医疗政策。这些地区的医疗基础设施不断完善，监管障碍降低，病患群体日益壮大。此外，不断增长的医疗费用支出和有利于商业发展的管治环境也为市场相关人员创造了有利条件。对创新伤口创伤护理和外科手术应用的需求不断增长，以及全球企业聚焦这些新兴市场带来的竞争格局的加剧，进一步提振了市场前景。随着人们对羊膜治疗益处的认识不断提高，预计这些地区的投资机会也将随之活性化。

目录

介绍

• 调查目标
• 调查范围
• 定义

调查方法

• 资讯收集
• 二手资料和一手资料方法
• 市场规模预测
• 市场假设与限制

执行摘要

• 全球市场展望
• 供需趋势分析
• 细分市场机会分析

市场动态与展望

• 市场规模
• 市场动态
  • 驱动因素和机会
  • 限制与挑战
• 波特分析

关键市场考察

• 关键成功因素
• 竞争程度
• 关键投资机会
• 市场生态系统
• 市场吸引力指数（2025）
• PESTEL 分析
• 总体经济指标
• 价值链分析
• 定价分析

全球羊膜市场规模（按产品类型和复合年增长率划分）（2026-2033 年）

• 冷冻保存的羊膜
• 脱水羊膜

全球羊膜市场规模（按应用及复合年增长率划分）（2026-2033 年）

• 外科性创伤
• 眼科
• 其他的

全球羊膜市场规模（按最终用途和复合年增长率划分）（2026-2033 年）

• 医院
• 门诊手术中心
• 专科诊所
• 研究和学术机构

全球羊膜市场规模及复合年增长率（2026-2033）

• 北美洲
  • 美国
  • 加拿大
• 欧洲
  • 德国
  • 西班牙
  • 法国
  • 英国
  • 义大利
  • 其他欧洲地区
• 亚太地区
  • 中国
  • 印度
  • 日本
  • 韩国
  • 亚太其他地区
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地区
• 中东和非洲
  • 海湾合作委员会国家
  • 南非
  • 其他中东和非洲地区

竞争资讯

• 前五大公司对比
• 主要企业的市场定位（2025 年）
• 主要市场参与者所采取的策略
• 近期市场趋势
• 公司市占率分析（2025 年）
• 主要企业公司简介
  • 公司详情
  • 产品系列分析
  • 依业务板块进行公司股票分析
  • 2023-2025年营收年比比较

主要企业简介

• MiMedx Group, Inc.（USA）
• Integra LifeSciences Holdings Corporation.（USA）
• Organogenesis Holdings Inc.（USA）
• Smith & Nephew plc.（UK）
• BioTissue Holdings Inc.（USA）
• Amnio Technology, LLC.（USA）
• Applied Biologics LLC.（USA）
• Celularity Inc.（USA）
• Corza Health, Inc.（USA）
• Skye Biologics, Inc.（USA）
• Human Regenerative Technologies, LLC.（USA）
• Katena Products Inc.（USA）
• TissueTech Inc.（BioTissue）（USA）
• Amniox Medical Inc.（USA）
• Laboratoire CCD.（France）
• VIVEX Biologics Inc.（USA）
• Merakris Therapeutics.（USA）
• Thea Pharma.（France）
• Allosure, Inc.（USA）
• Xtant Medical Holdings Inc.（USA）

结论与建议

Amniotic Membrane Market size was valued at USD 5.18 Billion in 2024 and is poised to grow from USD 5.96 Billion in 2025 to USD 18.37 Billion by 2033, growing at a CAGR of 15.1% during the forecast period (2026-2033).

The amniotic membrane (AM) is gaining traction in the healthcare market, particularly among ophthalmology and orthopedic specialists, due to its efficacy in treating various conditions and enhancing surgical outcomes. The rising patient population with related diseases drives the demand for innovative amniotic membrane products, allowing for more efficient surgical interventions. The growing inclination for tissue-based solutions in ophthalmic surgeries significantly contributes to market expansion, as these products promote quicker patient recovery. Additionally, the increasing popularity of aesthetic surgical procedures is expected to further fuel market growth. Technological advancements, including cryopreservation, bioengineering, and the development of biocompatible scaffolds, are enhancing the functionality of amniotic membranes, thereby improving tissue repair and regeneration capabilities, which aligns with the evolving needs of healthcare providers and patients alike.

Top-down and bottom-up approaches were used to estimate and validate the size of the Amniotic Membrane market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Amniotic Membrane Market Segments Analysis

Global Amniotic Membrane Market is segmented by Product, Application, End Use and region. Based on Product, the market is segmented into Cryopreserved Amniotic Membrane and Dehydrated Amniotic Membrane. Based on Application, the market is segmented into Surgical Wounds, Ophthalmology and Others. Based on End Use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Research Institutes and Academic Institutes. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Amniotic Membrane Market

The rising incidence of severe injuries among workers engaged in fieldwork is significantly driving the demand for swift and efficient healing therapies. Traumatic injuries, particularly among children and young adults, are predominantly caused by road accidents, which continue to be a pressing issue. With road safety concerns escalating and traffic congestion intensifying globally, the frequency of accidents is increasing. This surge in trauma cases directly contributes to the growth of the amniotic membrane market, as healthcare providers seek advanced solutions to facilitate recovery and healing for those affected by such injuries. As a result, the market for amniotic membranes is flourishing.

Restraints in the Amniotic Membrane Market

The amniotic membrane market faces significant challenges due to the high costs associated with producing these specialized products and their related services. The manufacturing of amniotic membrane products necessitates intricate biological processing and techniques that are essential for preserving their natural properties while ensuring safety. Maintaining stringent quality control, conducting thorough testing, and adhering to regulatory standards are crucial aspects of this production process, which collectively contribute to elevated expenses. As a result, the financial burden can create obstacles for patients, suppliers, and healthcare systems, potentially limiting access and adoption of these valuable therapies.

Market Trends of the Amniotic Membrane Market

The amniotic membrane market is witnessing significant growth driven by favorable healthcare policies in emerging economies, particularly in Asia-Pacific nations like China, India, and Brazil. These regions boast improved healthcare infrastructure, reduced regulatory barriers, and an expanding patient population. Additionally, increasing healthcare expenditures and pro-business governance create a conducive environment for market players. The burgeoning demand for innovative wound care and surgical applications, combined with a competitive landscape spurred by global players focusing on these emerging markets, further enhances market prospects. As awareness of the therapeutic benefits of amniotic membranes rises, investment opportunities in these regions are set to intensify.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Amniotic Membrane Market Size by Product & CAGR (2026-2033)

• Market Overview
• Cryopreserved Amniotic Membrane
• Dehydrated Amniotic Membrane

Global Amniotic Membrane Market Size by Application & CAGR (2026-2033)

• Market Overview
• Surgical Wounds
• Ophthalmology
• Others

Global Amniotic Membrane Market Size by End Use & CAGR (2026-2033)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Specialty Clinics
• Research Institutes and Academic Institutes

Global Amniotic Membrane Market Size & CAGR (2026-2033)

• North America (Product, Application, End Use)
  • US
  • Canada
• Europe (Product, Application, End Use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Application, End Use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Application, End Use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Application, End Use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• MiMedx Group, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Holdings Corporation. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Organogenesis Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc. (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• BioTissue Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amnio Technology, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Applied Biologics LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Celularity Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Corza Health, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Skye Biologics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Human Regenerative Technologies, LLC. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Katena Products Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• TissueTech Inc. (BioTissue) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amniox Medical Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratoire CCD. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VIVEX Biologics Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merakris Therapeutics. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thea Pharma. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Allosure, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Xtant Medical Holdings Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations